v3.26.1
Business Segment Information - Summary of EBIDTA by Reporting Segment (Detail) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 26,735 $ 28,918 $ 44,467 $ 48,407
Interest expense, net 6,085 3,950 11,749 8,456
Depreciation and amortization 13,273 16,871 26,766 51,302
Share-based compensation and long-term incentive plan expense 7,945 7,824 14,583 14,293
Foreign exchange impact 746 (2,751) 1,646 (3,795)
SeaSpine merger-related costs 572 4,886 503 6,016
Restructuring costs and impairments related to M6 product lines 1,085 3,354 1,338 15,480
Strategic investments 634 353 1,584 3,867
Acquisition-related fair value adjustments 868 (763) 1,618 (1,373)
Interest and loss on investments   (31) (16) (31)
Litigation and investigation costs 2,185 4,029 5,101 7,071
Employee Retention Credit   (2,854) (951) (2,854)
Employee transition costs 1,742   1,742  
Loss before income taxes (14,997) (14,223) (35,831) (66,356)
Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 25,589 26,433 45,990 45,949
Global Limb Reconstruction [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 1,146 2,485 (1,523) 2,458
Operating Segments [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 210,933 203,121 407,641 396,767
Non-GAAP Cost of sales 59,225 55,077 116,682 111,535
Non-GAAP Sales, general, and administrative 123,080 115,159 241,302 225,619
Non-GAAP Research and development 14,611 14,435 29,007 28,910
Other segment expenses 83 2,470 1,280 6,738
Non-GAAP Depreciation, amortization, and share-based compensation expense 12,801 12,938 25,097 24,442
Operating Segments [Member] | Global Spine [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 173,243 169,824 337,095 333,660
Non-GAAP Cost of sales 44,561 42,811 87,403 87,398
Non-GAAP Sales, general, and administrative 100,992 97,169 199,013 189,708
Non-GAAP Research and development 11,528 11,761 22,925 23,384
Other segment expenses 63 2,464 322 6,907
Non-GAAP Depreciation, amortization, and share-based compensation expense 9,490 10,814 18,558 19,686
Operating Segments [Member] | Global Limb Reconstruction [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA 37,690 33,297 70,546 63,107
Non-GAAP Cost of sales 14,664 12,266 29,279 24,137
Non-GAAP Sales, general, and administrative 22,088 17,990 42,289 35,911
Non-GAAP Research and development 3,083 2,674 6,082 5,526
Other segment expenses 20 6 958 (169)
Non-GAAP Depreciation, amortization, and share-based compensation expense 3,311 2,124 6,539 4,756
Corporate, Non-Segment [Member]        
Segment Reporting Information [Line Items]        
Segment Adjusted EBITDA $ 6,597 $ 8,273 $ 14,635 $ 16,331